Cargando…

Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy

BACKGROUND: This study investigates the predictive value of the systemic immune-inflammation index (SII), which was calculated as platelet × neutrophil/lymphocyte ratio, for all-cause mortality in patients with hypertrophic cardiomyopathy (HCM). METHODS: A total of 360 HCM patients were enrolled. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ziqiong, Ruan, Haiyan, Li, Liying, Wei, Xin, Zhu, Ye, Wei, Jiafu, Chen, Xiaoping, He, Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Academia 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693584/ https://www.ncbi.nlm.nih.gov/pubmed/34984097 http://dx.doi.org/10.48101/ujms.v126.8124

Ejemplares similares

Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy
por: Li, Liying, et al.
Publicado: (2023)

Application of the ALBI Scoring System for Mortality Outcome Prediction in Patients with Hypertrophic Cardiomyopathy
por: Qiao, Ping, et al.
Publicado: (2022)

Myocardial contraction fraction predicts mortality for patients with hypertrophic cardiomyopathy
por: Liao, Hang, et al.
Publicado: (2020)

The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study
por: Wang, Ziqiong, et al.
Publicado: (2023)

New metabolic health definition might not be a reliable predictor for mortality in the nonobese Chinese population
por: Wang, Ziqiong, et al.
Publicado: (2022)

U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients
por: Wang, Ziqiong, et al.
Publicado: (2020)

Relation between lymphocyte to monocyte ratio and survival in patients with hypertrophic cardiomyopathy: a retrospective cohort study
por: Chen, Zhonglan, et al.
Publicado: (2022)

New risk score model for identifying individuals at risk for diabetes in southwest China
por: Li, Liying, et al.
Publicado: (2021)

Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy
por: Liao, Hang, et al.
Publicado: (2021)

Thromboembolism in Patients with Hypertrophic Cardiomyopathy
por: Liu, Lu, et al.
Publicado: (2021)

Promotion of Healthy Lifestyles Alone Might Not Substantially Reduce Socioeconomic Inequity-Related Mortality Risk in Older People in China: A Prospective Cohort Study
por: Wang, Ziqiong, et al.
Publicado: (2023)

Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation
por: Zhang, Nixiao, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function
por: Tülüce, Selcen Yakar, et al.
Publicado: (2016)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype
por: Guglielmi, Valeria, et al.
Publicado: (2016)

The Influence of Angiotensin Converting Enzyme and Angiotensinogen Gene Polymorphisms on Hypertrophic Cardiomyopathy
por: Luo, Rong, et al.
Publicado: (2013)

Systemic Lupus Erythematosus Complicated with Hypertrophic Cardiomyopathy: A Case Report and Literature Review
por: Ma, Huihui, et al.
Publicado: (2021)

Association Between Depression and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
por: Hu, Hui‐Lin, et al.
Publicado: (2021)

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
por: Kuusisto, Johanna, et al.
Publicado: (2012)

Comparison of mortality and cause of death between adults with and without hypertrophic cardiomyopathy
por: Kwon, Soonil, et al.
Publicado: (2022)

Longitudinal Changes of Left Atrial Volume Index as a Prognosticator in Hypertrophic Cardiomyopathy
por: Kim, Sungseek, et al.
Publicado: (2023)

An Unusual Type of Hypertrophic Cardiomyopathy
por: Seo, Hye-Sun, et al.
Publicado: (2009)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

The systolic paradox in hypertrophic cardiomyopathy
por: Haland, Trine F, et al.
Publicado: (2017)

ECHOCARDIOGRAPHY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: Irpachi, Kalpna, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy masked by pericarditis
por: Nichols, Larry, et al.
Publicado: (2019)

The natural history of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m9tn8tcpr1d61anbb0k5qsn7lr